Clínica Baviera, S.A.

MCE CBAV.MC

Clínica Baviera, S.A. Gross Profit for the year ending December 31, 2023: USD 218.38 M

Clínica Baviera, S.A. Gross Profit is USD 218.38 M for the year ending December 31, 2023, a 18.01% change year over year. Gross profit is the difference between revenue and the cost of revenue, representing the profit earned from core business operations.

Clínica Baviera, S.A. Gross Profit for the year ending December 31, 2022 was USD 185.04 M, a 7.48% change year over year.
Clínica Baviera, S.A. Gross Profit for the year ending December 31, 2021 was USD 172.17 M, a 31.26% change year over year.
Clínica Baviera, S.A. Gross Profit for the year ending December 31, 2020 was USD 131.16 M, a 6.59% change year over year.
Clínica Baviera, S.A. Gross Profit for the year ending December 31, 2019 was USD 123.05 M, a 11.46% change year over year.

Key data

Date	Gross Profit	Operating Income	EBIT	EBITDA

MCE: CBAV.MC

Clínica Baviera, S.A.

CEO	Mr. Eduardo Baviera Sabater
IPO Date	April 3, 2007
Location	Spain
Headquarters	Paseo de la Castellana 20
Employees	1,326
Sector	Consumer Discretionary
Industries Eyewear Dental Care Drugstores & Retail Pharmacies

Description

Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, presbyopia, cataract, retina, pediatric ophthalmology, glaucoma, squint, cornea, neuroftalmología, vías lagrimales, and oculoplasty treatments. It operates approximately 90 centers in Spain, Germany, Austria, and Italy. The company is based in Madrid, Spain.

Key trends

Past 5 years